EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
[HTML][HTML] Recent development in x-ray imaging technology: Future and challenges
X Ou, X Chen, X Xu, L Xie, X Chen, Z Hong, H Bai… - Research, 2021 - spj.science.org
X-ray imaging is a low-cost, powerful technology that has been extensively used in medical
diagnosis and industrial nondestructive inspection. The ability of X-rays to penetrate through …
diagnosis and industrial nondestructive inspection. The ability of X-rays to penetrate through …
The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance …
Background Multiparametric magnetic resonance imaging (MRI) is validated for the
detection of clinically significant prostate cancer (csPCa), although patients with …
detection of clinically significant prostate cancer (csPCa), although patients with …
Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management
JA Eastham, GB Auffenberg, DA Barocas… - Journal of …, 2022 - journals.lww.com
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …
Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter …
TA Hope, M Eiber, WR Armstrong, R Juarez… - JAMA …, 2021 - jamanetwork.com
Importance The presence of pelvic nodal metastases at radical prostatectomy is associated
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …
[HTML][HTML] E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET
Rationale The development of consensus guidelines for interpretation of Prostate-Specific
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients …
Purpose: Prostate specific membrane antigen-targeted positron emission tomography/
computerized tomography has the potential to improve the detection and localization of …
computerized tomography has the potential to improve the detection and localization of …
[HTML][HTML] Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre …
Summary Background Lutetium-177 (177 Lu) prostate-specific membrane antigen (177 Lu-
PSMA) is a novel targeted treatment for patients with metastatic castration-resistant prostate …
PSMA) is a novel targeted treatment for patients with metastatic castration-resistant prostate …
[HTML][HTML] Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of …
Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …
Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for …
KM Chow, WZ So, HJ Lee, A Lee, DWT Yap… - European Urology, 2023 - Elsevier
Context Whether prostate-specific membrane antigen positron emission tomography (PSMA-
PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate …
PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate …